免疫检查点
免疫系统
癌症研究
肿瘤微环境
封锁
免疫疗法
免疫抑制
癌症
CXCR4型
癌症免疫疗法
医学
PD-L1
重编程
生物
免疫学
内科学
细胞
受体
遗传学
趋化因子
作者
Yuling Xiao,Jiang Chen,Hui Zhou,Xiaodong Zeng,Zhiping Ruan,Zhaoxia Pu,Xingya Jiang,Aya Matsui,Lingling Zhu,Zohreh Amoozgar,Dean Shuailin Chen,Xiangfei Han,Dan G. Duda,Jinjun Shi
标识
DOI:10.1038/s41467-022-28279-8
摘要
Immunotherapy with immune checkpoint blockade (ICB) has shown limited benefits in hepatocellular carcinoma (HCC) and other cancers, mediated in part by the immunosuppressive tumor microenvironment (TME). As p53 loss of function may play a role in immunosuppression, we herein examine the effects of restoring p53 expression on the immune TME and ICB efficacy. We develop and optimize a CXCR4-targeted mRNA nanoparticle platform to effectively induce p53 expression in HCC models. Using p53-null orthotopic and ectopic models of murine HCC, we find that combining CXCR4-targeted p53 mRNA nanoparticles with anti-PD-1 therapy effectively induces global reprogramming of cellular and molecular components of the immune TME. This effect results in improved anti-tumor effects compared to anti-PD-1 therapy or therapeutic p53 expression alone. Thus, our findings demonstrate the reversal of immunosuppression in HCC by a p53 mRNA nanomedicine when combined with ICB and support the implementation of this strategy for cancer treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI